bioRxiv · 10.1101/2020.10.08.329805
Oxygen-generating cryogels restore T cell-mediated cytotoxicity in hypoxic tumors
Abstract
Solid tumors are protected from antitumor immune responses due to their hypoxic microenvironments. Weakening hypoxia-driven immunosuppression by hyperoxic breathing of 60% oxygen has shown to be effective in unleashing antitumor immune cells against solid tumors. However, efficacy of systemic oxygenation is limited against solid tumors outside of lungs. Therefore, it is essential to develop targeted oxygenation alternatives to weaken tumor hypoxia as novel approaches to cancer immunotherapies. Herein, we report on injectable oxygen-generating cryogels (O2-cryogels) to reverse tumor-induced hypoxia. These macroporous biomaterials were designed to locally deliver oxygen, inhibit the expression of hypoxia-inducible genes in hypoxic melanoma cells, and reduce the accumulation of immunosuppressive extracellular adenosine. O2-cryogels enhance T cell-mediated secretion of cytotoxic proteins, restoring the killing ability of tumor-specific CTLs, both in vitro and in vivo. In summary, O2-cryogels provide a unique and safe platform to supply oxygen as a co-adjuvant in hypoxic tumors and improve cancer immunotherapies.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Colombani, T., Eggermont, L. J., Hatfield, S. M., Rezaeeyazdi, M., Memic, A., Sitkovsky, M. V., Bencherif, S. A.. 2020-10-09. Oxygen-generating cryogels restore T cell-mediated cytotoxicity in hypoxic tumors. https://doi.org/10.1101/2020.10.08.329805
Cite the original work for its findings. Save a collection to share your selection of sources.